A genetic linkage map of the human genome was constructed that consists of 1416 loci, including 279 genes and expressed sequences. The loci are represented by 1676 polymorphic systems genotyped with the CEPH reference pedigree resource. A total of 339 microsatellite repeat markers assayed by PCR are contained within the map, and of the 351 markers with heterozygosities of at least 70%, 205 are microsatellites. Seven telomere loci define physical and genetic endpoints for 2q, 4p, 7q, 8p, 1 4q, 1 6p, and 1 6q, and in other cases distal markers on the maps have been localized to terminal cytogenetic bands. Therefore, at least 92% of the autosomal length of the genome and 95% of the X chromosome is estimated to be spanned by the map. Since the maps have relatively high marker density and numerous highly informative loci, they can be used to map disease phenotypes, even for those with limited pedigree resources. The baseline map provides afoundation for achieving continuity of clone-based physical maps and for the development of a truly integrated physical, genetic, and cytogenetic map of the human.
A genetic linkage map of the human genome was constructed that consists of 1416 loci, including 279 genes and expressed sequences. The loci are represented by 1676 polymorphic systems genotyped with the CEPH reference pedigree resource. A total of 339 microsatellite repeat markers assayed by PCR are contained within the map, and of the 351 markers with heterozygosities of at least 70%, 205 are microsatellites. Seven telomere loci define physical and genetic endpoints for 2q, 4p, 7q, 8p, 1 4q, 1 6p, and 1 6q, and in other cases distal markers on the maps have been localized to terminal cytogenetic bands. Therefore, at least 92% of the autosomal length of the genome and 95% of the X chromosome is estimated to be spanned by the map. Since the maps have relatively high marker density and numerous highly informative loci, they can be used to map disease phenotypes, even for those with limited pedigree resources. The baseline map provides afoundation for achieving continuity of clone-based physical maps and for the development of a truly integrated physical, genetic, and cytogenetic map of the human.
Genetic linkage mapping has become an important technology applied to the study of human biology and, in particular, for the delineation of the molecular basis of disease through gene isolation and characterization of mutations in DNA. Once the chromosomal location of a disease-producing gene has been determined, fine structure genetic mapping narrows the region to be searched. Subsequent studies often include examination of known genes mapping to the area and isolation of new genes by positional cloning strategies. The success of this approach has been stunning, and the pace is accelerating rapidly, due in large part to the availability of sets of mapped genetic markers and improvements in physical mapping methods. Landmarks from the past few years include isolation of genes responsible for cystic fibrosis (1), neurofibromatosis (2) , and fragile X-linked mental retardation (3) . Since these disorders segregate as single Mendelian traits and because reasonably large pedigree resources were available, there was every expectation that the genes eventually would be cloned and that the molecular basis of the disorders would be determined quickly. This prediction has been fulfilled. It affective disorders could be resolved by this approach since they could be caused by multiple, independent genes and, in addition, might be influenced by environmental factors. Although progress in mapping bipolar affective disorder and schizophrenia has been slow (4) , evidence supporting the feasibility of this approach for common diseases has come from reports of the isolation of a gene responsible for colon cancer (5) ; mapping of a breast cancer locus (6) ; and verification, by linkage and mutation analysis, that a candidate gene (glucokinase) is responsible for a form of diabetes (7) .
Despite these successes, genetic linkage maps for the human chromosomes are not yet ideal for trait mapping. For example, the correspondence between the end points of the genetic linkage maps and the physical termini of chromosomes remains uncertain because only a few human telomeres have been identified in cloned DNA (8) (9) (10) . Therefore, the extent to which the human genome is encompassed by genetic maps is not fully known. In addition, centromere-specific polymorphisms are available for only a few chromosomes, limiting the definition of these structures within the context of linkage maps. The most significant weakness of the currently available genetic maps, however, is the lack of highly informative markers that are evenly spaced along the chromosome. Most of the mapped markers are restriction fragment length polymorphisms (RFLPs) (11) (13) , tend to cluster near the ends of chromosomes (14, 15) . Furthermore, only a small number of cloned genes have been incorporated into linkage maps because of the low degree of restriction site polymorphism within or nearby these coding sequences.
In addition to their utility for disease gene localization, genetic linkage maps could prove valuable for clone-based physical mapping of whole chromosomes, particularly as a means of facilitating closure attempts, since the position of contigs along the chromosome and locations of gaps could be readily identified. Until quite recently, the advantage of applying genetic mapping to this purpose and its use in focusing DNA sequencing efforts have not been fully appreciated because of the lack of high-resolution maps containing markers that could also be readily used as physical mapping reagents.
Because of the perceived need to quickly and systematically develop a high-resolution genetic linkage map of the human genome, several intemational efforts have been launched during the past several years. At the National Institutes of Health (NIH), the National Center for Human and Genome Research (NCHGR) initiated a program to develop "index maps" for each of the human chromosomes consisting of genetic markers with interval spacing of no more than 15 cM (centimorgans) and marker heterozygosity of at least 70% (16) . Similar efforts to improve the existing genetic maps are also under way under the auspices of the European Genetic Linkage Map Project (EUROGEM) and Genethon (17) .
These efforts have been greatly facilitated by the recognition that polymorphisms originating from microsatellite repeat elements, abundant and ubiquitous throughout the genome, could be exploited for genetic mapping if they were assayed by the polymerase chain reaction (PCR) and DNA sequencing gels (18) . A relatively large number of these markers have already been developed (19) . Furthermore, microsatellite markers have proven to be highly informative and well distributed throughout the genome. The presence of these markers in regions adjacent to coding sequences has enabled the incorporation of cloned genes into genetic linkage maps (20) . The markers are also "ready-made" sequence tagged (22) .
Finally, the development of statistical methods embodied in computer programs (23) (24) (25) (26) have made possible construction of high-resolution genetic maps containing 100 or more markers. In addition, the availability of high-speed and relatively inexpensive workstations for linkage calculations has made this type of research accessible to a large number of laboratories.
Map-making has been transformed over the past 10 years from a relatively arcane pursuit by a small number of human genetics groups to an intensive, highly collaborative process, often involving many laboratories. This activity has led to the publication of many independent maps presented in a variety of formats. Therefore, it is not possible to readily achieve a "view" of the entire genome. Such a "view" is crucial for those interested in designing efficient strategies for screening the human genome in search of locations for heritable traits. It also has become apparent that defining chromosome deletions by means of mapped genetic markers is quite useful for pinpointing the locations of putative tumor suppressor genes implicated in a wide variety of neoplasias [for example, see (27, 28) ].
To unify a large amount of genotypic data currently available from the CEPH database and collaborating laboratories, members of the genetic mapping community have joined together to construct a genetic linkage map of the human genome which is presented here in a common format. The map should provide a useful tool for disease gene mapping, for defining chromosome deletions, and for assessing current progress and future directions for human genetic linkage mapping.
Results
Genetic markers and genotypic data. Characteristics of the 1676 genetic markers used to construct the genetic maps reported in this study are summarized in Table 1 (see Ap- pendix, pages 148 to 159). Cytogenetic band assignments for markers that have been physically mapped are indicated along with the relevant literature citations (a 68 subset of these assignments is also shown in Fig. 1 14) , and microsatellite polymorphisms assayed by PCR (339). These data are available to interested investigators (29) .
Error checking of genotype data was routinely performed prior to map construction. For example, the inheritance of polymorphic alleles in families was tested for parental exclusions (an indicator that individuals in the pedigree have been mislabeled or that genotypes have been incorrectly scored). The chromosome 1 genotype data underwent multiple checks during the building process for the CEPH consortium map, as discussed in Dracopoli et al. (30) , as did much of the data used in additional map construction projects of the CEPH consortium (31) . All groups (with the exception of those working on chromosomes 11 and 18) checked the CEPH VS data for errors, usually through examining the CRI-MAP CHROMPIC output (25) for apparent close double crossovers and intralocus recombinants. Nearly all laboratories retyped suspect data from microsatellite markers (most of which were found as apparent double recombinants). Although no error checking was performed on the CEPH database for chromosome 18, after it was merged with new data, all suspect data were regenotyped and corrected before the final map was produced. Few laboratories retyped RFLP markers, but when autoradiographs were accessible, questionable data were reexamined; for example, all the CRI-RFLP markers on chromosome 20 
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This map is a reproduction of the CEPH consortium linkage map of human chromosome 1 (30 (38) , the observed length is consistent with genetic measurements for chromosome 1 (which is very close in physical length to chromosome 2) and similar with respect to the number of mapped markers. We estimate that more than 95% of the physical length of chromosome 2 (255 Mb) (38) is contained within the genetic map since one of the most distal markers on the short arm, ACP1, has been cytogenetically mapped to 2p25-pter, and the q terminus is contained within a telomere YAC clone (8) The average interval between markers is about 7 cM although there are some gaps occurring in the telomeric regions. However, no gap is greater than 20 cM on the sex-average map. The sex-specific maps are 276 cM and 399 cM for males and females, respectively. For some intervals, there is significantly more recombination occurring in males compared to females. Seventeen microsatellite markers have been incorporated in the map, and of the 13 markers with heterozygosities in excess of 70%, 11 are microsatellites that are relatively evenly distributed along the length of the map. The sex-average map length of this framework map is identical to the 39-locus map reported by Mills et al. (36) . However, the male map is 10 cM shorter and the female map 9 cM longer than the Mills et al. map (36) . Ten of the 81 markers reported in this map have heterozygosities of at least 70%, and six of these are microsatellite markers (from a total of 25) assayed by PCR. The largest gaps in the map are 26 cM in the female map and 18 cM in both the sex-average and the male maps. In the sex-average map, the average interval distance is 7 cM, with 28 of the 38 intervals being less than 10 cM. Differences in position-specific recombination rates for the chromosome 4 linkage map have been recently described (41) . Except for the most distal portions of the map that are represented by highly informative RFLPs, the current map contains highly informative microsatellite markers that are relatively evenly spaced. In addition, since there are currently no gaps greater than 20 cM on the sex-average map, the map reported here provides a useful framework against which to carry out linkage studies.
The map was built with markers from more than 200 available for chromosome 5 in the CEPH database (V5). Except for one marker, D5S7 1, which has a heterozygosity of 31%, selection of markers was based on heterozygosities of at least 40%, and on children (more than 100) from matings where at least one parent is heterozygous. We constructed the map with the program package LINKAGE (23) and an automated algorithm (34) that adds "test markers" to a primary map after evaluating their location with multipoint analysis. The 20-marker primary map (loci marked "°" in Fig. 1 (42) . Physical mapping data allowed us to locate the centromere between HPRTP2 and D5S76; more precise localization was not possible because we were able to map D5S21 only within a 1-LOD unit confidence interval. The order of markers on our map agrees with two published maps (42, 43) ; on a third, however (44) , the order of D5S83 and D5S71 was reversed, with odds of 10:1. When the location of D5S83 on our map was determined by including the information of three adjacent loci on each side, the odds against inversion with D5S71 were 13360:1. 52 loci uniquely placed, including markers physically localized to the p terminal band and several 7q telomere markers. Because of the relatively low number of informative meioses, the centromere locus D7Z2 is not uniquely placed at 1000:1 odds, and maps instead to five genetic intervals spanning 18 cM on the sex-average map. The sex-average map length is 267 cM, the female map is 355 cM, and the male map is 207 cM. We estimate that the map covers at least 97% of the chromosome. This map is 50% longer than the map length predicted on the basis of chiasma counts (38) . The largest genetic gaps between uniquely placed loci are 21 cM in females (ERV3-D7S398) and 12.8 in males (D7S372-D7S396). The map has an overall sex-average intermarker distance of 2.36 cM and is one of the most densely mapped chromosomes in the human genome at the present time.
The genetic map order agrees well with previously described chromosome 7 maps (48) . While the map is dominated by RFLPs, 13 (8, 53) . In addition, different allele systems detected by the same telomere probe map to 2qter (see chromosome 2 description). The extent of coverage is less certain for the long arm because the most distal marker, GPT, could lie at any point along the interval q24.2-qter. As this band is roughly 5% of the chromosome, we estimate that the genetic map includes approximately 95% of the physical length (155 Mb) (38) . Consistent with other observations for human chromosomes, we find that the female map length (298 cM) is roughly 1.5 times the length found for males (183 cM). The map reported here includes genotypic data from 22 loci used to construct a recently reported map (54 (64) map are included in the current 1000:1 odds map. Thirty-six of the loci on this map are detected with Southern blotting and 11 are detected with PCR amplification (65) . Twelve markers with more than 70% heterozygosity were used to construct this map.
The largest gap on the sex-average map is 12.6 cM and is between D13S127 and TUBBP2. The average distance between uniquely placed loci is 4.8 cM. The ratio of female-to-male recombination is 1.3:1. Five intervals with statistically significant sex differences were observed. Only one of these intervals (D13S1-D13S127) shows an excess of recombination in females (X2 = 6.12, P = 0.013). An excess of recombination in males was observed near the distal end of the map between D13S49 and D13S54 (x2 = 6.81, P = 0.009). The sublocalization of markers agrees with the genetic map except for ATPlAL1, which was mapped more distally with somatic cell hybrids (66) , and D13S64, which was mapped to a more proximal location (67 The current genetic map is based on 67 polymorphisms from 50 loci. These have been placed into one of the 50 cytogenetically defined intervals along this chromosome (73) and genotyped on the CEPH reference families. The map extends from D16S85, which is within 170 to 430 kb of the 16p telomere (10), to D16S44, which is within 230 kb of the 16q telomere (74) , and covers more than 99% of the physical length of this chromosome. The sex-average map is 162 cM long (133 cM in males, 199 cM in females). The framework genetic map includes 33 loci in an order that is compatible with an independently determined physical order on the cytogenetic map (73) . The comprehensive genetic map of all 50 loci is anchored to the cytogenetic map. The average distance between markers is 3.3 cM. The present genetic map contains ten loci with minimum heterozygosity of 70% and six (CA), repeat microsatellite markers, which are the first of many now being characterized for this chromosome (75) . Comparison of the sex-specific recombination rates reveals that the female map is 1.5 times larger than the male map, which departs slightly from the 1.7 genome average (38 51 unambiguously ordered markers qualify as "index markers" with heterozygosities of at least 70% (from a total of 21). Selection of 14 of these on the basis of optimal spacing provides a nearly complete index marker map of chromosome 17, and there are five microsatellite markers that can be assayed by PCR. New, highly polymorphic genetic markers have been placed in and around regions containing genes responsible for neurofibromatosis 1 (NFl) at 17q1 1.2; CharcotMarie-Tooth (CMT) neuropathy; and familial breast cancer (BRCAI), which has been localized to 1 7q2 1 and linked to several loci shown on the map presented here (D17S250, RARA, D17S41) (6), and within several regions where loss of heterozygosity has been observed in various neoplasias.
The new map confirms the distribution of sex-specific differences in male and female recombination rates along chromosome 17 that was described previously (78 The chromosome 19 baseline linkage map was built around a framework of 15 microsatellites and one RFLP (the marker at locus D19S20). Markers were chosen for the framework on the basis of high informativeness, position and spacing along the chromosome, and the ability to be typed by PCR. The framework was constructed primarily with the program package CRI-MAP (25) , but pairwise LOD scores and CROSS-MAP (35) were also utilized. The order for pairs of markers along the framework was supported by likelihood ratios (against inversion) of at least 110: 1 and also by seven or more clear recombination events between each pair of markers. An additional set of 31 polymorphisms, some PCR-based but mainly RFLPs, including polymorphisms at 12 gene loci, was added to the 74 framework in positions that were supported with odds of at least 1000:1 as determined by the maximum likelihood calculations. Duplicate typing of the dinucleotide repeat polymorphism at the APOC2 locus and other error checking procedures resulted in an estimate of typing error for the PCRbased markers of approximately 0.5%. Female recombination rates exceeded male rates in the interior of the map from D19S177 to HRC, while the pter end of the map showed an excess of male recombination. The map is consistent with and extends previously published linkage maps for this chromosome (84) . The sex-average map is 147 cM in length and consists of 50 loci, 33 of which were uniquely placed with global odds of 1000:1 and, with the exception of D20S40 and D20S18, local support of 1000:1. Fortythree of the markers are from the CEPH V5 database 126 of these were previously included in a map by Hazan et al. (17) and five additional markers are recently mapped microsatellite markers (one of these was originally typed by RFLPsJ. D20S6, included in previous chromosome 20 maps (12, 17, 85) and previously designated a "reference marker" for chromosome 20 (86) , was not included in the current map because of observed intralocus recombinants in three independent data sets. Twenty-six of the 50 markers on the map have heterozygosities of at least 70% and 34 are microsatellite markers that can be typed by PCR.
The map spans 162 cM in females and 135 cM in males. On the basis of a likelihood ratio test from two-point analyses, females show significantly (P < 0.05) higher recombination frequencies than males over much of the chromosome, including the regions spanned from D20S61-D20S58, D20S18-SRC, PLCI-ADA, and D20S33-D20S4. In one region (D20S25-GNAS) there was a significant excess of male recombination. The average marker spacing on the female and male maps is 5 and 4 cM, respectively, with the largest distance between two adjacent markers equal to 14 cM on the female map and 23 cM on the male map. The human chromosome 21 map represents a subset of 13 evenly spaced and SCIENCE * VOL. 258 * 2 OCTOBER 1992 highly informative polymorphic loci selected from a collection of more than 50 genetic markers. A comprehensive map of 42 polymorphic markers genotyped in CEPH pedigrees by PCR will be reported elsewhere (87). The map consists of 13 loci, of which 11 can be genotyped by PCR-based methods. The heterozygosity of these markers ranges from 60 to 95%, with 12 of the 13 markers having heterozygosities greater than 70%. The chromosome 21 map has a male genetic length of 57 cM, a female genetic length of 78 cM, and a sex-average genetic length of 67 cM. On the basis of the cytogenetic localization of the terminal loci (D2 1S 120 and D2 1S 1 12), we estimate that the genetic map spans almost the entire physical length of the long arm of the chromosome (39 Mb) (38) . On the sexaverage map the 12 marker intervals range from 3.2 to 7.9 cM, with an average spacing of 5.6 cM. Sex-specific differences in recombination frequency were examined along the chromosome arm by testing each interval. Significant sex differences were observed at the terminal intervals: D2 1S120-D2 1S11 where females showed greater recombination than males, and for the interval D21S171-D21S112 where males showed greater recombination than females. There appears to be excessive recombination toward the telomere of the chromosome. Linkage maps for chromosome 21 that contain polymorphic markers typed by Southern blotting in the CEPH or the Venezuelan reference pedigrees have been reported (88) . The map presented here is considerably shorter than the previously published maps in CEPH pedigrees, presumably because rigorous error checking has eliminated false recombination events. The current map includes approximately 95% of the physical length of the chromosome and is comprised of highly informative, closely spaced markers. l-11-0W*W*..,W.,. ..;-",-' .. -1~ with the Dumanski et al. map (33) ] the orders are identical and the distances are quite similar. Chromosome X J. C. Murraya, S. J. Ludwigsenb, K. H.
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The linkage map of the X chromosome contains 71 markers, a relatively modest number considering that this chromosome represents approximately 5% of the genome. Whereas the majority of markers are RFLP-based, there is now an increasing availability of microsatellite polymorphisms, which will greatly enhance the quality of this map over the next year. Fifteen markers in the map have heterozygosities of at least 70%, including 6 of the 20 microsatellites mapped (90) . At the present time, the genetic length of 208 cM is similar to that of the chiasma-based (38) and previously published linkage maps (12, 91 (12) consisted almost entirely of RFLPs (397, plus five protein polymorphisms), and only 7% of these markers (28) had heterozygosities of 70% or greater. In the current map 339 markers are microsatellites and they constitute more than 50% of markers with heterozygosity of at least 70%. Although 80% of the markers in the map reported here are RFLPs, the rapid integration of microsatellites [the first of which were reported just 3 years ago (18)] predicts that they will become the dominant markers on the map. The popularity of microsatellites over RFLPs is due to their high degree of informativeness, convenience of assay by PCR, relatively even distribution throughout the genome, and availability (from publication of primer sequences).
The most densely mapped chromosomes are 7 and 17, with 112 and 116 loci mapped, respectively. Considering that chromosome 17 is about 50% as large in predicted physical distance, but comparable in estimated genetic length (based on chiasma, chromosome 17 is 196 cM and chromosome 7 is 178 cM), it constitutes the most densely mapped chromosome per megabase spanned. Except for chromosomes 3 and 5 (where the average marker spacing is 6.4 and 7 cM, respectively), each chromosome map has an average marker spacing of less than 5 cM.
As the Y chromosome has no homolog and only undergoes genetic exchange at the pseudoautosomal region on Yp with an Xpter segment, a genetic map for this part of the genome is not presented. Even so, the pseudoautosomal region has provided an opportunity to compare genetic to physical distance and to study sex-specific recombination. The genetic distance of the pseudoautosomal region is estimated at 4 to 18 cM in female meioses and at 50 cM in male meioses (no more than several megabases) (94) .
All of the chromosome maps consist of continuous linkage groups. In a few cases (chromosomes 2q, 4p, 7q, 8p, 14q, 16p, and 16q) genetic map closure has been achieved through telomeric polymorphisms, but in the absence of clone-based physical maps, most of our estimates of physical genome coverage rely on cytogenetic assignments of markers to Giemsastained metaphase chromosomes or on fractional length measurements obtained in similar FISH experiments. Traditional cytogenetic banding patterns have relatively low resolution (for example, approximately 6 to 10 Mb per band) and are often useless as a check for the order of closely linked genetic markers. In addition, it is not known whether dark staining and light staining bands have equal DNA content. However newer methods of interphase mapping have allowed the orientation of closely linked markers on the physical map and could be important in resolving confusing orders in genetic data. For the X chromosome (although the telomeres are not represented in the map presented here), the long-range physical maps of the p and q telomere regions (92, 95) 22 ). However, except for ribosomal RNA genes, it is unlikely that many additional genes reside in these regions since they appear to consist almost entirely of aand P-alphoid repeat elements (62, 97) .
One limitation of the current chromosome maps is the low number and uneven representation of genes and expressed sequences. For example, more than 1500 cloned genes have been reported (86) yet less than 20% have been incorporated into the genetic maps reported here. This is mainly due to the low rate of RFLP polymorphism previously found at these loci, and it is expected that since microsatellites have been found in abundance within introns or nearby gene loci, this deficiency will be corrected. In fact, of the 279 gene loci incorporated in the map, 66 are now represented by microsatellites (ten of these also have associated RFLPs). One important reason for precisely localizing genes in the maps is to recognize and test them as candidate disease genes. It is worth noting that although glucokinase has long been considered a candidate gene for diabetes susceptibility, it was not until recently, when highly informative microsatellite markers at this locus became available, that the appropriate studies linking the disease phenotype with the gene were made possible (7, 98) .
The genome map presented here covers an autosomal sex-average distance of 4702 cM, which is about 20% larger than the mean length estimated from chiasma counts (3734 cM). Since we estimate that as much as 10% of the physical length of the genome is not included in the map, we expect that the apparent map inflation is likely due to genotyping errors. Several groups have estimated error rates from comparisons of markers that were typed in duplicate (for example, see chromosome 1 description). On the basis of these observations of a 0.5 to 1.0% error rate per polymorphic system typed (a 0.5-to 1.0-cM increase per system, and a total of 1604 autosomal systems), the overall increase in autosomal map size would be about 800 to 1600 cM, which is within the range of the map length increase that is observed.
We must address the likelihood that genotyping errors leading to map expansion may also indicate potentially incorrect marker orders. Buetow's Monte Carlo simulation analysis of linkage data indicated that as multipoint maps approach a 1-cM interlocus resolution, even a relatively low 0.5% typing error rate would result in 5% incorrect marker orders (for maps constructed with LOD 3 criteria) (99) . However, genotyping error rates of even 1.5% had minimal effect in producing incorrect map orders for maps with less (2 cM) resolution (99) . In general, the data sets used to produce the current maps were not rigorously checked, and in the future marker orders for regions with high marker densities should be rechecked by duplicate typings, particularly where clustering of apparent recombinant events in families is observed (1X). Fig. 1 (pages 77 to 83) . Genetic linkage maps for 23 human chromosomes. Graphical representations are shown for each of the 22 autosomes and the X chromosome (103). The cumulative length for each sex-average genetic map is indicated at the top of each map graphic (in centimorgans; recombination fractions were converted to centimorgans by means of Kosambi mapping function). In order to best illustrate the map intervals and display the marker names, the chromosomes are not strictly represented according to their physical and genetic size. Loci uniquely placed with odds for order of at least 1000:1 are tethered to the map (to the right of the vertical map line) and are represented by HGM gene names and D segment numbers where available. A "*" indicates loci with heterozygosities of at least 70%. Microsatellite markers assayed by PCR are shown in italics. The intermarker spacing in centimorgans is indicated to the left of the map line. The sex-average map also shows markers that are not uniquely ordered. The genetic intervals for these markers are indicated by solid vertical lines to the left of the corresponding intervals on the map line. These intervals represent the placement of the markers at 1000:1 odds except for chromosome 3 (only the most likely intervals for placement at 100:1 odds are shown). The marker names are located to the left of the interval lines, and when more than one marker maps to the same interval, the markers are listed (the order for these groups of markers with respect to each other has not been determined). Dashed interval lines indicate excluded regions for the marker. Representative tie points between markers included in the genetic maps that have also been cytogenetically mapped are drawn between the sex-average map and the chromosomal idiogram (to the right of the sex-average map). Brackets indicate the physical map position of markers based on cytogenetic mapping data (referenced in Table 1 ; see pages 148 to 159). Arrows at the end points of tie lines between the idiogram and the genetic maps indicate a mapped polymorphism from a cloned telomere segment. The idiograms depict the Giemsa staining pattern at 550-band resolution for metaphase chromosomes [ISCN 550 G-bands (37)], except for chromosome 16, which illustrates 850-band resolution. Loci that may be in an inverted order are indicated with a brace (}) on the sex-average map. For the chromosome 5 map graphic, a "°" indicates the primary map markers used in the early stages of map construction. Chromosomes 6 and 7 have brackets on the genetic map lines indicating regions spanned by the HLA and TCRB gene clusters, both of which have intralocus recombination (detailed genetic maps for these regions are not shown).
useful to quickly place new markers. Because these maps depict a comprehensive collection of markers available for given regions, they are useful for more detailed mapping once a disease gene has been subregionally localized. Since most microsatellite markers are highly informative, simply genotyping a new marker in five to eight CEPH families (101) should be sufficient to quickly place it in the context of the current maps (that is, from a two-point analysis). At the present time the maps provide a "baseline" upon which future mapping efforts will be focused. It is expected that "index maps" for each of the chromosomes will be completed within the next year and these will provide even better tools for disease gene searches. Genetic maps are never complete. Inherent in the activity is a continuous process of modification as new markers are developed and as existing data are reexamined and corrected. We are now reaching a point in the genome project where, for the first time, as in other model organisms (for example, 102), human genetic and clone-based mapping over relatively large distances will converge, and it is anticipated full integration of genetic, cytogenetic, and physical mapping information will be possible, thereby providing a new "view" of the genome upon which to base future biological studies. ................................................................................. 
